Analytical Data
-
Gene name
BAI1
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O14514
-
Expression Region
Ala31~Pro350
-
Molecular Weight
64kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BAI1 (Brain-specific Angiogenesis Inhibitor 1) is a member of the BAI family of adhesion G protein-coupled receptors and plays a critical role in various biological processes, including neurodevelopment and angiogenesis. Initially identified as a regulator of angiogenesis, BAI1 has garnered attention for its potential implications in neurological disorders and tumor biology. Research highlights its unique ability to modulate cellular responses through interactions with ligands and intracellular signaling pathways, which may underlie its role in maintaining vascular stability and promoting neuronal survival. Its involvement in synaptic function and plasticity suggests that BAI1 could be a crucial factor in cognitive processes and neurodegenerative diseases. Given the complexities of its function, the study of BAI1 recombinant proteins is essential for understanding its biological roles and therapeutic potential. Advances in recombinant DNA technology have enabled the production of BAI1 proteins, facilitating in-depth studies on their structure, function, and interactions. This research could lead to novel therapeutic strategies for diseases such as cancer and neurodegenerative conditions, where BAI1's regulatory effects on angiogenesis and neuronal health are particularly relevant. As such, the exploration of BAI1 recombinant proteins is a promising area of investigation in contemporary biomedical research.
